STADA Figure of the Month: 44 Percent of Germans Want to Abolish Prescription Requirements
07/31/2019 - 01.24 PM . Press Release
Bad Vilbel, July 31, 2019 – How sensible are prescription requirements for contraceptive or potency pills? “Not sensible at all”, say 44 percent of Germans who would like to get rid of prescription requirements. Its biggest adversaries in the federal republic are 18 to 34-year-olds: 58 percent of them would like to buy their medication without a slip issued by their doctor. Amongst people of the age of 50 and above, only 35 percent share this view.
Still, in a Europe-wide comparison, Germany belongs to the proponents of the prescription requirement. Only Italians feel less inclined to abolish prescription requirements (37 percent). In countries like Poland (61 percent) or Belgium (59 percent), far more than half of the respondents are convinced that prescription requirements are unnecessary.
These are the results of the STADA Health Report 2019, a representative study with 18.000 respondents from nine countries. On behalf of STADA Arzneimittel AG, the market research institute Kantar Health surveyed 2.000 people each from Belgium, France, Germany, Italy, Poland, Russia, Serbia, Spain and the United Kingdom on the topic of “The Future of Your Health”. Further information on the STADA Health Report and much more can be found at: www.yourhealth.stada
About STADA Arzneimittel AG
STADA Arzneimittel AG is a publicly-listed company with headquarters in Bad Vilbel, Germany. The company focuses on a two pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription Consumer Health products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In financial year 2018, STADA achieved adjusted Group sales of Euro 2,330.8 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of Euro 503.5 million. As of December 31, 2018, STADA employed 10,416 people worldwide.
Additional information for journalists:
STADA Arzneimittel AG / Media Relations / Stadastrasse 2–18 / 61118 Bad Vilbel – Germany / Phone: +49 (0) 6101 603-165 / Fax: +49 (0) 6101 603-215 / E-Mail: press(at)stada.de Or visit us on the Internet at www.stada.com/press